Princeton, 8540, NJ,
United States
Theradex Oncology Technographics
Theradex Oncology Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Theradex Oncology and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 650 Theradex Oncology employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Theradex Oncology has purchased the following applications: and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Theradex Oncology is running and its propensity to invest more and deepen its relationship with or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Theradex Oncology revenues, which have grown to $118.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Theradex Oncology intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Theradex Oncology Tech Stack and Enterprise Applications
IT Decision Makers and Key Stakeholders at Theradex Oncology
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Theradex Oncology Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||